Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-34579
Titel: Abuse of nutmeg seeds: Detectable by means of liquid chromatography-mass spectrometry techniques?
VerfasserIn: Manier, Sascha K.
Wagmann, Lea
Weber, Armin A.
Meyer, Markus R.
Sprache: Englisch
Titel: Drug Testing and Analysis
Bandnummer: 13
Heft: 7
Seiten: 1440-1444
Verlag/Plattform: Wiley
Erscheinungsjahr: 2021
Freie Schlagwörter: GC-MS
LC-HRMS/MS
LC-LIT-MSn
metabolism
nutmeg
DDC-Sachgruppe: 610 Medizin, Gesundheit
Dokumenttyp: Journalartikel / Zeitschriftenartikel
Abstract: Numerous case reports of intoxications with nutmeg seeds (Myristica fragrans, Houtt.) can be found in literature often following their abuse, as psychotropic effects were described after ingestions of large doses. The successful detection of the main ingredients of the nutmeg seeds essential oil elemicin, myristicin, and safrole, as well as their metabolites in human urine by gas chromatography coupled to mass spectrometry (GC-MS) was already described. The aim of this study was to investigate the detectability of the main ingredients of nutmeg seeds and their metabolites in human blood and urine samples using liquid chromatography coupled to linear ion trap mass spectrometry (LC-LIT-MSn ) and liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS/MS) after nutmeg seed abuse. Sample material of three individuals was retrospectively investigated after a systematic screening approach indicated an intoxication with nutmeg seeds as a likely cause of symptoms. Metabolic patterns in plasma and urine using GC-MS were comparable with those described in earlier publications. Investigations using hyphenated liquid chromatography techniques lead to the detection of myristicin and safrole, as well as further metabolites not described using GC-MS and revealed sulfation as an additional Phase II metabolic pathway. These results might help to detect or confirm future intoxications with nutmeg seeds by using LC-MS techniques.
DOI der Erstveröffentlichung: 10.1002/dta.3027
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-345798
hdl:20.500.11880/31652
http://dx.doi.org/10.22028/D291-34579
ISSN: 1942-7611
1942-7603
Datum des Eintrags: 26-Aug-2021
Bezeichnung des in Beziehung stehenden Objekts: Supporting Information
In Beziehung stehendes Objekt: https://analyticalsciencejournals.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fdta.3027&file=dta3027-sup-0001-Supplementary_Material_0_8.pdf
Fakultät: M - Medizinische Fakultät
Fachrichtung: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professur: M - Prof. Dr. Markus Meyer
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Datei Beschreibung GrößeFormat 
dta.3027.pdf752,58 kBAdobe PDFÖffnen/Anzeigen


Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons Creative Commons